Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Hyperplasia
Description
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (3)
Phase 3 Indicated Drugs (7)
Phase 1 Indicated Drugs (6)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (72)
Ankara Yildirim Beyazıt University
Bangabandhu Sheikh Mujib Medical University
Handok Pharmaceuticals Co., Ltd.
I.M. Sechenov First Moscow State Medical University
Organization Involved with Phase 3 Indications (77)
Cantonal Hospital of St. Gallen
Catholic University of Sacred Heart, Rome
Chinese Academy of Medical Sciences
Health Ever Bio-Tech Co., Ltd.
Institut National de la Santé Et de la Recherche Médicale, France
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
New York Presbyterian Hospital
Pharmaceutical Research Associates, Inc. (PRA)
South Florida Medical Research
The University of Texas, Dallas
University of California, Los Angeles
Organization Involved with Phase 2 Indications (67)
Feinstein Institute for Medical Research
French National Agency for Research on AIDS and Viral Hepatitis
National Center for Research Resources (NCRR)
National Institute of Dental and Craniofacial Research (NIDCR)
Queensland University of Technology
Organization Involved with Phase 1 Indications (35)
Dongkook Pharmaceutical Co., Ltd.
Fundación de Ayuda a la Investigación sobre la Hipertensión pulmonar
Hammersmith Medicines Research
Organization Involved with Other Experimental Indications (16)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.